Suppr超能文献

T1N0M0 口腔鳞状细胞癌选择性颈清扫术的适应证。

The Indications for Elective Neck Dissection in T1N0M0 Oral Cavity Squamous Cell Carcinoma.

机构信息

Maxillofacial, Head and Neck Fellow, Oral and Maxillofacial Department, Waikato District Health Board, Hamilton, New Zealand.

Maxillofacial House Surgeon, Oral and Maxillofacial Department, Waikato District Health Board, Hamilton, New Zealand.

出版信息

J Oral Maxillofac Surg. 2021 Aug;79(8):1779-1793. doi: 10.1016/j.joms.2021.01.042. Epub 2021 Feb 24.

Abstract

PURPOSE

The management of the clinically node-negative neck in T1 oral cavity squamous cell carcinoma (SCC) is controversial. The purpose of this study was to investigate tumor characteristics of surgically managed patients with T1N0 oral cavity SCC and determine the possible benefits of elective neck dissection (END).

MATERIALS AND METHODS

A retrospective cohort study was conducted assessing outcomes for patients with stage I oral SCC at Waikato Hospital, New Zealand, between 2008 and 2018. Clinical staging was based on the American Joint Committee on Cancer Cancer Staging Manual, 8 Edition. Patients with T1N0 SCC either had an END or had the neck observed. These data were used to determine the rate of occult nodal disease, recurrence rate, and survival. Data collected included patient demographics, location, tumor characteristics including differentiation, depth of invasion (DOI), perineural invasion (PNI), lymphovascular invasion, closest histologic margin, management of the neck, the number of pathologic lymph nodes, adjuvant treatment, recurrence, and survival.

RESULTS

A total of 70 patients were included in the study (40 male, 30 female; age range 30 to 91; mean age 65 years). Twenty-seven (38.6%) patients underwent END, whereas 43 patients (61.4%) were observed. Occult nodal metastases were diagnosed in 6 of 27 (22.2%) patients who underwent END. Regional relapse occurred in 7 of 43 (16.3%) patients who were observed. Risk factors for nodal disease included increasing DOI ≥ 3 mm (P = .049), poor tumor differentiation (P = .003), and presence of PNI (P = .002). Negative prognostic factors for overall survival included male gender (P = .02, hr = 3.55, CI for HR (1.18, 10.65)), presence of PNI (P = .001, hr = 4.52, CI for HR (1.77, 11.57)), and locoregional recurrence (P < .005, hr = 6.55, CI for HR (2.69, 15.98)). Six of the 7 tumors that relapsed in the neck after observation had a primary tumor DOI < 3 mm.

CONCLUSIONS

There is little data published for management outcomes of the node-negative neck in stage I oral squamous cell carcinoma. Given salvage neck dissection carries a poorer prognosis, END should be recommended for all T1N0 oral SCC with DOI ≥ 3 mm. In cases of DOI < 3 mm undergoing primary ablation only, a staging neck dissection as a second procedure should be considered in the presence of poor tumor differentiation or PNI on final histology.

摘要

目的

T1 口腔鳞状细胞癌(SCC)临床淋巴结阴性颈部的管理存在争议。本研究的目的是研究接受手术治疗的 T1N0 口腔 SCC 患者的肿瘤特征,并确定选择性颈部清扫术(END)的可能获益。

材料和方法

对新西兰怀卡托医院 2008 年至 2018 年间接受 I 期口腔 SCC 治疗的患者进行了回顾性队列研究。临床分期基于美国癌症联合委员会癌症分期手册,第 8 版。T1N0 SCC 患者行 END 或观察颈部。这些数据用于确定隐匿性淋巴结疾病的发生率、复发率和生存率。收集的数据包括患者的人口统计学资料、位置、肿瘤特征,包括分化程度、浸润深度(DOI)、神经周围侵犯(PNI)、血管淋巴管侵犯、最近的组织学边缘、颈部处理、病理淋巴结数量、辅助治疗、复发和生存情况。

结果

共有 70 例患者纳入研究(男 40 例,女 30 例;年龄 30 至 91 岁;平均年龄 65 岁)。27 例(38.6%)患者行 END,43 例(61.4%)患者行观察。27 例行 END 的患者中,有 6 例(22.2%)诊断为隐匿性淋巴结转移。43 例观察患者中有 7 例(16.3%)发生区域复发。淋巴结疾病的危险因素包括 DOI≥3mm(P=0.049)、肿瘤分化差(P=0.003)和存在 PNI(P=0.002)。总生存的不良预后因素包括男性(P=0.02,HR=3.55,CI 为 HR(1.18,10.65))、存在 PNI(P=0.001,HR=4.52,CI 为 HR(1.77,11.57))和局部区域复发(P<0.005,HR=6.55,CI 为 HR(2.69,15.98))。观察后颈部复发的 7 个肿瘤中,有 6 个原发肿瘤 DOI<3mm。

结论

目前关于 I 期口腔鳞状细胞癌阴性颈部管理的结果数据很少。鉴于挽救性颈部清扫术预后较差,对于所有 DOI≥3mm 的 T1N0 口腔 SCC,应推荐行 END。对于仅行原发消融术的 DOI<3mm 病例,如果最终组织学检查存在肿瘤分化差或 PNI,应考虑作为二期手术的分期性颈部清扫术。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验